Stay updated on Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAn NIH grant/contract note for 2018 was added to the funding disclosures. The revision tag was updated from v3.6.5 to v3.6.6, replacing the previous revision.SummaryDifference0.0%

- Check23 days agoChange DetectedMelanoma, the related topics heading, and the MedlinePlus Genetics link were removed from the page. This consolidates the page's related-topic references to focus more on the study details.SummaryDifference0.1%

- Check30 days agoChange DetectedMelanoma and related topics: MedlinePlus Genetics were added to the page. The Plain Language Summary section was removed.SummaryDifference0.1%

- Check38 days agoChange DetectedA new revision tag, Revision: v3.6.5, appears on the page while the previous tag Revision: v3.6.4 is removed. This reflects a deployment/version update rather than a change to study details or navigation.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded a new revision tag: Revision: v3.6.4. The previous Revision: v3.6.3 and references to melanoma-related topics were removed.SummaryDifference0.1%

- Check59 days agoChange DetectedNew related-topic entries were added: Melanoma and MedlinePlus Genetics, under the related topics section.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.